Stock Research: Assertio Therapeutics

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Assertio Therapeutics

NasdaqGS:ASRT US04545L1070
26
  • Value
    79
  • Growth
    1
  • Safety
    Safety
    74
  • Combined
    47
  • Sentiment
    18
  • 360° View
    360° View
    26
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Assertio Holdings, Inc. is a pharmaceutical company offering differentiated products to patients. The company operates in the pharmaceutical industry with marketed products like ROLVEDONTM, INDOCIN, Sympazan, Otrexup, SPRIX, and CAMBIA. It has commercial capabilities including marketing and market access. In the last fiscal year, the company had a market cap of $64 million, profits of $86 million, and revenue of $125 million with 58 employees.

more
Index
NASDAQ
D.J. US Pharmaceutical
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
79 78 74 89
Growth
1 27 19 19
Safety
Safety
74 96 100 15
Sentiment
18 60 67 3
360° View
360° View
26 84 85 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
66 77 48 54
Opinions Change
50 50 95 50
Pro Holdings
n/a 51 49 24
Market Pulse
13 47 18 2
Sentiment
18 60 67 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
79 78 74 89
Growth
1 27 19 19
Safety Safety
74 96 100 15
Combined
47 91 87 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
96 96 100 82
Price vs. Earnings (P/E)
93 89 86 88
Price vs. Book (P/B)
83 73 71 70
Dividend Yield
1 1 1 1
Value
79 78 74 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
19 12 63 11
Profit Growth
8 92 1 27
Capital Growth
6 1 77 35
Stock Returns
20 53 7 73
Growth
1 27 19 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
61 61 66 29
Refinancing
96 92 85 29
Liquidity
21 69 77 38
Safety Safety
74 96 100 15

Similar Stocks

Discover high‑ranked alternatives to Assertio Therapeutics and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: